GOLM1 and hepatocellular carcinoma: In order to determine the GP73 concentration in ordinary clinical laboratories, we in this study developed and tested a LTIA based on 3 monoclonal antibodies for measurement of GP73 concentration, in both HCC patients and healthy individuals.